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INTRODUCTION 
Pleural tuberculosis is the most common presentation of 
extrapulmonary tuberculosis and the most common cause 
of pleural effusion worldwide.1,2  Conventional methods 
for the diagnosis of tubercular pleural effusion have 
proven inefficient. It is well known that because of the 
low number (or even absence) of M. Tuberculosis in 
pleural effusion and direct examination of pleural fluid 
and Ziehl-Neelsen staining requires bacillar 
concentrations of 10,000/ml and, therefore, has a low 
sensitivity (0 to 1%).3,4 Although a culture is more 
sensitive (11 to 50%), 5,6 it requires 2 to 6 weeks to grow 
Mycobacterium tuberculosis and a minimum of 10 to 
100 viable bacilli. The sensitivity of pleural biopsy 
specimens is reportedly higher whether by culture (39 to 
79%) 4,5 or histologic evaluation (71 to 80%).3,4 
However, this procedure requires greater expertise, is 
more invasive, and is subject to sampling error. 
Radiological imaging techniques are also sometime 
given confusing diagnosis. Several relatively newer 
techniques have been developed to make the diagnosis 
including recognition of serum IgG antibody to selected 
Mycobacterium antigen by Enzyme Immunoassay (EIA) 
and identification of Mycobacterium DNA through gene 
amplification by Polymerase Chain Reaction (PCR), 
interferon gamma. Serum IgG towards tubercular antigen 
is poorly correlated with extrapulmonary tuberculosis 
and technique is costly, required sophisticated 
instrumentation. 7 PCR has relatively low sensitivity in 
body fluids (42-81%) 8-10 and is fairly expensive. 
Moreover, it gives positive result for mycobacterium in 
patients with history of treated tuberculosis. Non-viable 
organisms are detected and negative PCR makes the 
diagnosis very unlikely. The sensitivity of an elevated 
interferon level appears better (89-99%) 
11-12
 but 
relatively only few studies of its use have been reported 
and the assay is expensive and cannot be done in routine 
laboratory. So, the present study was performed to search 
a quick, simple, low cost investigation for easy and rapid 
diagnosis of tubercular pleural effusion and resolve the 
diagnostic dilemma. One such biochemical parameter is 
estimation of Adenosine deaminase (ADA) and its 
isoenzymes activity in pleural fluid.  
Adenosine deaminase an enzyme required for purine 
degradation is widely distributed in human tissues 13. 
ADA helps in proliferation and differentiation of 
lymphocytes especially T lymphocytes. ADA is a 
significant indicator of active cellular immunity.14 There 
are 2 isoforms of ADA, ADA-1 and ADA-2. The ADA1 
isoenzyme is found in all the cells with highest 
concentration in lymphocytes and monocytes, whereas 
ADA-2 is released by monocyte macrophages 15 when 
they are stimulated by the presence of live 
microorganisms in their interior. Hence, this study was 
designed and conducted to assess the role of pleural fluid 
ADA2 activity in the early laboratory diagnosis of 
tubercular pleural effusion. 
MATERIAL AND METHODS 
Study area 
The present study was conducted in the department of 
Biochemistry with the collaboration of department of 
Medicine and Pathology of Burdwan Medical College, 
Burdwan, and West Bengal, India.  
Selection of subjects 
In this hospital based cross-sectional study a total of 87 
patient paediatric age group varying from 20 to 80 years 
old were selected as case by simple random sampling 
after informed consent had been received from parents or 
guardians of the subjects between February 2011 and 
May 2013. Out of these 55 were suffering from 
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tubercular pleural effusion and rest of the 32 patients 
were grouped as non-tubercular exudative pleural 
effusion, among which sixteen patients were due to 
empyema and malignant causes each. 
In present study, the diagnosis of tubercular and non-
tubercular pleural effusion was made by clinical 
examination as well as examining pleural fluid using (i) 
Cell count (ii) Histopathological examination (iii) 
Quantitative estimation of glucose and protein (iv) 
Histopathological examination (v) Gram’s stain, Ziehl-
Neelson (Z-N) stain (vi) cultured on Lowenstein-Jensen 
medium (vii) Radiological investigations.  
Collection of samples  
Thoracocentesis was performed in all the patients to 
obtained pleural fluid under aseptic precautions where 
about 30 ml of pleural fluid was obtained. and the 
collected fluid was centrifuged for 10-15 min at 1500 
rpm; supernatant was separated and stored at -200C for 
ADA and its isoenzyme activity analysis.  
Assay of total ADA and ADA isozyme activity 
The activities of the total ADA and the ADA isozymes 
were assayed using an automatic analyzer (TBA-80FR; 
Toshiba, Tokyo, Japan) with a commercial kit according 
to the instructions of the manufacturer (Toyobo, Osaka, 
Japan). The enzyme activity was determined by 
quantifying inosine liberated from the substrate, 
adenosine (10 mM). Inosine was converted by purine 
nucleoside phosphorylase into hypoxanthine, which was 
further converted by xanthine oxidase into uric acid and 
hydrogen peroxide. The hydrogen peroxide was then 
converted into the quinone dyes by peroxidase, 4-
aminoantipyrine, and N-ethyl-N-(2-hydroxy-3-
sulfopropyl)-m-toluidine, and the absorbance at 548/700 
nm was measured. ADA2 activity was measured in the 
presence 0.35 mM erythro-9-(2-hydroxy-3- nonyl) 
adenine hydrochloride (EHNA; Toyobo) since ADA1 
activity is blocked by EHNA at that concentration but 
ADA2 activity is unaffected. 16 Total ADA activity was 
measured in the absence of EHNA, and ADA1 activity 
was then calculated by subtracting the ADA2 activity 
from the total activity. For this study we used 
commercial calibrator material (DDR-1, Toshiba, Tokyo, 
Japan marketed by ERBA) and control material [DDC-
1R (Fluid/CSF), Toshiba, Tokyo, Japan marketed by 
ERBA]. Intra assay CV% was 2.3 and inter assay CV% 
was 3.1. 
Statistical analysis  
The data for biochemical analysis was subjected to 
standard statistical analysis using the Statistical Package 
for Social Science (SPSS) 11.5 software for windows. 
RESULT 
The age of the patients ranged from 20-75 years and their 
characteristics are shown in Table 1.  Among eighty 
seven pleural effusion patients, 45 (51.72%) were male 
and 42 (48.28%) were female. 
 
Table 1:  Personal profile and clinical details of healthy persons and patients suffering from pleural effusion 
Groups Male Female Age (years) 
Empyemic pleural effusion (n = 16) 7 9 20-55 
Tubercular pleural effusion (n = 55) 28 27 21-59 
Malignant  pleural effusion (n = 16) 10 6 45-80 
 
The mean value of pleural fluid total ADA activity in 
tubercular, empyemic and malignant pleural fluid were 
23.44, 19.79 and 18.29 IU/L respectively. The ADA2 
activity was 6.31, 15.38 and 6.28 in empyemic, 
tubercular and in malignant pleural effusion respectively 
as shown in the Table 2. 
 
Table 2: ADA activity in CSF in control, tubercular, viral, pyogenic, cerebral malaria 
Groups  Total ADA activity in 
pleural fluid (IU/L) 
ADA2 activity in pleural 
fluid (IU/L) 
Empyemic pleural effusion (n = 16) 19.79 ± 6.69 6.31 ± 1.37 
Tubercular pleural effusion (n = 55) 23.44 ± 11.96 15.38 ± 2.86 
Malignant  pleural effusion (n = 16) 18.29 ± 3.92 6.28 ± 1.8 
n = number of subject; Values are mean ± SD 
 
In the Table 3 it was observed that when comparison of 
means of all exudative pleural effusions was analysed it 
was found that the CSF ADA activity among all type of 
pleural effusion under study had no significant different 
among them (p > 0.05) 
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Table 3: ANOVA with Bonferroni correction showing multiple comparisons between different types of exudative 
pleural effusions with significance of difference 
 
⃰ p value significant ( p < 0.05) at 95% Confidence interval (CI); 1 = Tubercular pleural effusion, 2 = Empyema, 3 = Malignant pleural effusion. 
But when isoenzyme of ADA that is ADA2 was used as 
a parameter to compare among the all exdutative cause 
of pleural effusion it was found that CSF ADA2 activity 
in case of tubercular pleural effusion was significantly 
elevated than other types of exudative pleural effusion as 
shown in the Table 4. 
 
Table 4: ANOVA with Bonferroni correction showing multiple comparisons between different types of exudative 
pleural effusion with significance of difference 
٭ p value significant ( p < 0.05) at 95% Confidence interval (CI); 1 = Tubercular pleural effusion, 2 = Empyema, 3 = Malignant pleural effusion. 
The usefulness of CSF ADA2 level as a biomarker for 
diagnosis of tubercular pleural effusion was evaluated 
using Receiver Operative Characteristic (ROC) curve 
analysis and the optimal cut-off value was determined to 
be 19.6 IU/L (Figure 1). The area under the curve (AUC) 
for suspected tubercular pleural effusion group was 
0.933 and standard error (SE) was 0.032 (95% 
confidence interval (CI) =86.1% - 99.2%, P <0.001). 
Based on the cut-off value of 19.6 IU/L, the pleural fluid 
ADA2 sensitivity and specificity were 82.45% and 
97.82% respectively. Positive predictive value was 
96.18% and negative predictive value was 84.7%. The 
accuracy of the test in suspected tubercular pleural 
effusion cases was 89.1% (Table 5).
 
Table 5: Validity of CSF ADA2 as a diagnostic test in suspected cases of tubercular pleural effusion 
Study Group Sensitivity % 
(CI)  
Specificity % 
(CI)  
PPV % (CI)  NPV % (CI)  Accuracy %  
Tubercular pleural 
effusion 
82.45  
 
97.82  
 
96.18  
 
84.7  
 
89.1 
 
 
Figure 1: Receiver Operative Characteristic (ROC) curve of CSF ADA2 activity. Diagonal line indicates the line of no 
discrimination. Area Under the ROC Curve (AUC) curve is 0.933 
Dependent 
variable 
Factors (I) Factors (J) Mean difference (I-J) Significance at 
95% CI 
ADA activity 
(IU/L) in 
pleural fluid 
1 2 3.65 0.319 
3 5.15 0.098 
2 1 -3.65 0.319 
3 1.5 0.376 
3 1 -5.15 0.098 
2 -1.5 0.376 
Dependent variable Factors (I) Factors (J) Mean difference (I-
J) 
Significance at 95% 
CI 
ADA2 activity 
(IU/L) in pleural 
fluid 
1 2 9.07 <0.001⃰ 
3 9.1 <0.001⃰ 
2 1 -9.07 <0.001⃰ 
3 0.03 0.945 
3 1 -9.1 <0.001⃰ 
2 -0.03 0.945 
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DISCUSSION 
Exudative lymphocytic pleural effusions are commonly 
encountered in clinical practice but they often constitute 
difficult diagnostic problems. The three most common 
causes are tubercular, malignant and empyemic.
17
 For 
tuberculosis, the limitation of diagnostic tests are few 
positive staining and culture from pleural fluid, and time 
consuming for identification.
18,19
 So the present study was 
conducted to choose a diagnostic parameter that will help to 
diagnose properly and as early as possible to minimize the 
morbidity and mortality. ADA measurement in pleural fluid 
is the simple and inexpensive test that was used as 
parameter where cellular immunity is stimulated as in 
tuberculosis 
20,21
 and it was found that there was no 
significant difference of pleural fluid ADA activity in all 
types of exudative pleural effusion and thus the yield of 
total ADA may be low in setting to differentiate tubercular 
from other types of  exudative  pleural effusion as one old 
study. 
22
 The possible explanation may be from ADA value 
in most assays detected total ADA which includes ADA-1 
and ADA-2. Thus, fluid with high cell counts can have high 
total ADA and may be undifferentiated from tubercular 
pleural effusion. 
23
But determination of the individual 
ADA2 isoenzyme in the present study could help in 
distinguishing between the increase activity in CSF 
especially between tubercular and non-tubercular causes as 
ADA 2 isoenzyme was found to be primarily responsible for 
total ADA activity in tubercular origin, which mostly 
reflects monocyte-macrophage activity by live 
phagocytosed microorganisms. 
24
 
ADA2 has a good diagnostic potential to differentiate 
tubercular from other forms of exudative pleural effusion. In 
the present study CSF ADA2 activity 19.8 IU/L as a cut-off 
value exhibited a sensitivity of 81.65%, specificity of 
97.42% for the diagnosis of tubercular pleural effusion. In 
addition to this, the positive predictive value of test is 
96.85% with overall accuracy being 88.2%. Thus a cut-off 
CSF ADA2 level of 19.6 IU/L may differentiate tubercular 
from non-tubercular pleural effusion in this study area.  
CONCLUSION 
We concluded that the ADA2 activity instead of total ADA 
in tubercular pleural effusion is much higher than the other 
aetiology. Using 19.6 IU/L as the cut off, it is possible to 
avoid other expensive, lengthy, non-reliable investigation to 
diagnose tubercular pleural effusion. Thus, activity of CSF 
ADA2 estimation seems to have the potential for being a 
single test for the diagnosis of pleural effusion of tubercular 
origin tubercular in developing countries where prevalence 
of tuberculosis is quite high. 
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